Patent 7622507 was granted and assigned to ACEA Biosciences on November, 2009 by the United States Patent and Trademark Office.
The present invention provides substituted di-, tri-, tetra- and penta-sulfide compounds and compositions, and methods of using the same for the treatment and/or prevention of a cell proliferative disorder. The present invention also provides methods for preparing trisulfide compounds and compositions.